OMCL vs TFX: fair value comparison
Omnicell, Inc. and Teleflex Incorporated · Updated 2026-09-07
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Healthcare, OMCL currently sits closer to the top of our discount ranking.
| OMCL | TFX | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $37.65 | $141.56 |
| 12-month range | $29.96–$48.70 | $103.36–$140.48 |
| Sector rank | #54 of 113 Healthcare | #56 of 113 Healthcare |
| Quality grade | D | D |
| Leverage | Low | Low |
| Margin trend | — | Stable |
| Revenue growth | — | Modest |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Downtrend | — |
| DCF cross-check | — | Fairly Valued |
| 52-week position | The lower-middle quarter | The top quarter |
Full single-stock breakdowns: OMCL fair value analysis · TFX fair value analysis